nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—CYP2D6—Fingolimod—multiple sclerosis	0.0824	0.135	CbGbCtD
Propafenone—ABCB1—Methylprednisolone—multiple sclerosis	0.0563	0.0921	CbGbCtD
Propafenone—CYP3A4—Fingolimod—multiple sclerosis	0.0524	0.0856	CbGbCtD
Propafenone—ABCB1—Mitoxantrone—multiple sclerosis	0.0411	0.0672	CbGbCtD
Propafenone—ABCB1—Betamethasone—multiple sclerosis	0.0366	0.0599	CbGbCtD
Propafenone—ABCB1—Prednisolone—multiple sclerosis	0.0361	0.0591	CbGbCtD
Propafenone—ABCB1—Prednisone—multiple sclerosis	0.0341	0.0558	CbGbCtD
Propafenone—CYP3A4—Methylprednisolone—multiple sclerosis	0.0338	0.0552	CbGbCtD
Propafenone—CYP2C8—Dexamethasone—multiple sclerosis	0.0315	0.0515	CbGbCtD
Propafenone—CYP3A4—Triamcinolone—multiple sclerosis	0.0256	0.0418	CbGbCtD
Propafenone—CYP3A4—Mitoxantrone—multiple sclerosis	0.0246	0.0402	CbGbCtD
Propafenone—CYP2C9—Dexamethasone—multiple sclerosis	0.022	0.0359	CbGbCtD
Propafenone—CYP3A4—Betamethasone—multiple sclerosis	0.0219	0.0359	CbGbCtD
Propafenone—CYP3A4—Prednisolone—multiple sclerosis	0.0217	0.0354	CbGbCtD
Propafenone—ABCB1—Dexamethasone—multiple sclerosis	0.0213	0.0348	CbGbCtD
Propafenone—CYP3A4—Prednisone—multiple sclerosis	0.0205	0.0334	CbGbCtD
Propafenone—CYP2D6—Dexamethasone—multiple sclerosis	0.0201	0.0328	CbGbCtD
Propafenone—ABCB1—Methotrexate—multiple sclerosis	0.0171	0.028	CbGbCtD
Propafenone—CYP3A4—Dexamethasone—multiple sclerosis	0.0128	0.0209	CbGbCtD
Propafenone—Carvedilol—SELE—multiple sclerosis	0.00248	0.243	CrCbGaD
Propafenone—Carvedilol—VCAM1—multiple sclerosis	0.00236	0.232	CrCbGaD
Propafenone—Quinapril—SLC15A2—multiple sclerosis	0.00188	0.184	CrCbGaD
Propafenone—Benazepril—SLC15A2—multiple sclerosis	0.00163	0.16	CrCbGaD
Propafenone—Mirabegron—BCHE—multiple sclerosis	0.0013	0.128	CrCbGaD
Propafenone—Mirabegron—ALB—multiple sclerosis	0.000533	0.0524	CrCbGaD
Propafenone—Shock—Methylprednisolone—multiple sclerosis	0.000183	0.000552	CcSEcCtD
Propafenone—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000183	0.000551	CcSEcCtD
Propafenone—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000183	0.00055	CcSEcCtD
Propafenone—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000182	0.00055	CcSEcCtD
Propafenone—Loss of consciousness—Betamethasone—multiple sclerosis	0.000182	0.00055	CcSEcCtD
Propafenone—Epistaxis—Methotrexate—multiple sclerosis	0.000182	0.000549	CcSEcCtD
Propafenone—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000182	0.000549	CcSEcCtD
Propafenone—Paraesthesia—Prednisolone—multiple sclerosis	0.000182	0.000549	CcSEcCtD
Propafenone—Tachycardia—Triamcinolone—multiple sclerosis	0.000182	0.000549	CcSEcCtD
Propafenone—Mental disorder—Prednisone—multiple sclerosis	0.000182	0.000548	CcSEcCtD
Propafenone—Nausea—Azathioprine—multiple sclerosis	0.000182	0.000548	CcSEcCtD
Propafenone—Tachycardia—Methylprednisolone—multiple sclerosis	0.000182	0.000548	CcSEcCtD
Propafenone—Skin disorder—Methylprednisolone—multiple sclerosis	0.000181	0.000545	CcSEcCtD
Propafenone—Erythema—Prednisone—multiple sclerosis	0.000181	0.000545	CcSEcCtD
Propafenone—Malnutrition—Prednisone—multiple sclerosis	0.000181	0.000545	CcSEcCtD
Propafenone—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000181	0.000544	CcSEcCtD
Propafenone—Agranulocytosis—Methotrexate—multiple sclerosis	0.00018	0.000543	CcSEcCtD
Propafenone—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00018	0.000542	CcSEcCtD
Propafenone—Convulsion—Dexamethasone—multiple sclerosis	0.00018	0.000542	CcSEcCtD
Propafenone—Convulsion—Betamethasone—multiple sclerosis	0.00018	0.000542	CcSEcCtD
Propafenone—Hypertension—Betamethasone—multiple sclerosis	0.000179	0.00054	CcSEcCtD
Propafenone—Hypertension—Dexamethasone—multiple sclerosis	0.000179	0.00054	CcSEcCtD
Propafenone—Asthenia—Mitoxantrone—multiple sclerosis	0.000178	0.000535	CcSEcCtD
Propafenone—Myalgia—Dexamethasone—multiple sclerosis	0.000177	0.000532	CcSEcCtD
Propafenone—Myalgia—Betamethasone—multiple sclerosis	0.000177	0.000532	CcSEcCtD
Propafenone—Anxiety—Betamethasone—multiple sclerosis	0.000176	0.00053	CcSEcCtD
Propafenone—Anxiety—Dexamethasone—multiple sclerosis	0.000176	0.00053	CcSEcCtD
Propafenone—Discomfort—Dexamethasone—multiple sclerosis	0.000175	0.000526	CcSEcCtD
Propafenone—Discomfort—Betamethasone—multiple sclerosis	0.000175	0.000526	CcSEcCtD
Propafenone—Haemoglobin—Methotrexate—multiple sclerosis	0.000174	0.000525	CcSEcCtD
Propafenone—Hypotension—Methylprednisolone—multiple sclerosis	0.000174	0.000524	CcSEcCtD
Propafenone—Pain—Prednisolone—multiple sclerosis	0.000174	0.000523	CcSEcCtD
Propafenone—Haemorrhage—Methotrexate—multiple sclerosis	0.000174	0.000523	CcSEcCtD
Propafenone—Hepatitis—Methotrexate—multiple sclerosis	0.000174	0.000523	CcSEcCtD
Propafenone—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000171	0.000516	CcSEcCtD
Propafenone—Vision blurred—Prednisone—multiple sclerosis	0.00017	0.000513	CcSEcCtD
Propafenone—Urethral disorder—Methotrexate—multiple sclerosis	0.00017	0.000512	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00017	0.000512	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00017	0.000511	CcSEcCtD
Propafenone—Oedema—Dexamethasone—multiple sclerosis	0.000169	0.00051	CcSEcCtD
Propafenone—Oedema—Betamethasone—multiple sclerosis	0.000169	0.00051	CcSEcCtD
Propafenone—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000169	0.00051	CcSEcCtD
Propafenone—Insomnia—Triamcinolone—multiple sclerosis	0.000169	0.000509	CcSEcCtD
Propafenone—Insomnia—Methylprednisolone—multiple sclerosis	0.000169	0.000508	CcSEcCtD
Propafenone—Infection—Betamethasone—multiple sclerosis	0.000168	0.000507	CcSEcCtD
Propafenone—Infection—Dexamethasone—multiple sclerosis	0.000168	0.000507	CcSEcCtD
Propafenone—Ill-defined disorder—Prednisone—multiple sclerosis	0.000168	0.000505	CcSEcCtD
Propafenone—Paraesthesia—Triamcinolone—multiple sclerosis	0.000168	0.000505	CcSEcCtD
Propafenone—Feeling abnormal—Prednisolone—multiple sclerosis	0.000167	0.000504	CcSEcCtD
Propafenone—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000167	0.000504	CcSEcCtD
Propafenone—Visual impairment—Methotrexate—multiple sclerosis	0.000167	0.000504	CcSEcCtD
Propafenone—Anaemia—Prednisone—multiple sclerosis	0.000167	0.000503	CcSEcCtD
Propafenone—Shock—Betamethasone—multiple sclerosis	0.000167	0.000502	CcSEcCtD
Propafenone—Shock—Dexamethasone—multiple sclerosis	0.000167	0.000502	CcSEcCtD
Propafenone—Dyspnoea—Triamcinolone—multiple sclerosis	0.000166	0.000501	CcSEcCtD
Propafenone—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000166	0.0005	CcSEcCtD
Propafenone—Nervous system disorder—Betamethasone—multiple sclerosis	0.000166	0.0005	CcSEcCtD
Propafenone—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000166	0.0005	CcSEcCtD
Propafenone—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000166	0.0005	CcSEcCtD
Propafenone—Tachycardia—Dexamethasone—multiple sclerosis	0.000165	0.000498	CcSEcCtD
Propafenone—Tachycardia—Betamethasone—multiple sclerosis	0.000165	0.000498	CcSEcCtD
Propafenone—Dyspepsia—Triamcinolone—multiple sclerosis	0.000164	0.000495	CcSEcCtD
Propafenone—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000164	0.000494	CcSEcCtD
Propafenone—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000164	0.000493	CcSEcCtD
Propafenone—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000164	0.000493	CcSEcCtD
Propafenone—Malaise—Prednisone—multiple sclerosis	0.000163	0.000491	CcSEcCtD
Propafenone—Vertigo—Prednisone—multiple sclerosis	0.000162	0.000489	CcSEcCtD
Propafenone—Eye disorder—Methotrexate—multiple sclerosis	0.000162	0.000489	CcSEcCtD
Propafenone—Syncope—Prednisone—multiple sclerosis	0.000162	0.000488	CcSEcCtD
Propafenone—Tinnitus—Methotrexate—multiple sclerosis	0.000162	0.000487	CcSEcCtD
Propafenone—Anorexia—Dexamethasone—multiple sclerosis	0.000162	0.000486	CcSEcCtD
Propafenone—Anorexia—Betamethasone—multiple sclerosis	0.000162	0.000486	CcSEcCtD
Propafenone—Urticaria—Prednisolone—multiple sclerosis	0.000161	0.000486	CcSEcCtD
Propafenone—Cardiac disorder—Methotrexate—multiple sclerosis	0.000161	0.000485	CcSEcCtD
Propafenone—Fatigue—Triamcinolone—multiple sclerosis	0.000161	0.000485	CcSEcCtD
Propafenone—Fatigue—Methylprednisolone—multiple sclerosis	0.000161	0.000484	CcSEcCtD
Propafenone—Pain—Triamcinolone—multiple sclerosis	0.00016	0.000481	CcSEcCtD
Propafenone—Loss of consciousness—Prednisone—multiple sclerosis	0.000159	0.000479	CcSEcCtD
Propafenone—Hypotension—Dexamethasone—multiple sclerosis	0.000158	0.000477	CcSEcCtD
Propafenone—Hypotension—Betamethasone—multiple sclerosis	0.000158	0.000477	CcSEcCtD
Propafenone—Angiopathy—Methotrexate—multiple sclerosis	0.000157	0.000474	CcSEcCtD
Propafenone—Vomiting—Mitoxantrone—multiple sclerosis	0.000157	0.000474	CcSEcCtD
Propafenone—Immune system disorder—Methotrexate—multiple sclerosis	0.000157	0.000472	CcSEcCtD
Propafenone—Convulsion—Prednisone—multiple sclerosis	0.000157	0.000472	CcSEcCtD
Propafenone—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000156	0.000471	CcSEcCtD
Propafenone—Hypertension—Prednisone—multiple sclerosis	0.000156	0.00047	CcSEcCtD
Propafenone—Rash—Mitoxantrone—multiple sclerosis	0.000156	0.00047	CcSEcCtD
Propafenone—Dermatitis—Mitoxantrone—multiple sclerosis	0.000156	0.00047	CcSEcCtD
Propafenone—Headache—Mitoxantrone—multiple sclerosis	0.000155	0.000467	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000154	0.000465	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000154	0.000465	CcSEcCtD
Propafenone—Myalgia—Prednisone—multiple sclerosis	0.000154	0.000464	CcSEcCtD
Propafenone—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000154	0.000463	CcSEcCtD
Propafenone—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000154	0.000462	CcSEcCtD
Propafenone—Anxiety—Prednisone—multiple sclerosis	0.000153	0.000462	CcSEcCtD
Propafenone—Alopecia—Methotrexate—multiple sclerosis	0.000153	0.000462	CcSEcCtD
Propafenone—Insomnia—Betamethasone—multiple sclerosis	0.000153	0.000462	CcSEcCtD
Propafenone—Insomnia—Dexamethasone—multiple sclerosis	0.000153	0.000462	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000153	0.00046	CcSEcCtD
Propafenone—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000152	0.000459	CcSEcCtD
Propafenone—Paraesthesia—Betamethasone—multiple sclerosis	0.000152	0.000458	CcSEcCtD
Propafenone—Paraesthesia—Dexamethasone—multiple sclerosis	0.000152	0.000458	CcSEcCtD
Propafenone—Discomfort—Prednisone—multiple sclerosis	0.000152	0.000458	CcSEcCtD
Propafenone—Mental disorder—Methotrexate—multiple sclerosis	0.000152	0.000458	CcSEcCtD
Propafenone—Malnutrition—Methotrexate—multiple sclerosis	0.000151	0.000455	CcSEcCtD
Propafenone—Erythema—Methotrexate—multiple sclerosis	0.000151	0.000455	CcSEcCtD
Propafenone—Hypersensitivity—Prednisolone—multiple sclerosis	0.00015	0.000451	CcSEcCtD
Propafenone—Dyspepsia—Dexamethasone—multiple sclerosis	0.000149	0.000449	CcSEcCtD
Propafenone—Dyspepsia—Betamethasone—multiple sclerosis	0.000149	0.000449	CcSEcCtD
Propafenone—Urticaria—Triamcinolone—multiple sclerosis	0.000148	0.000447	CcSEcCtD
Propafenone—Urticaria—Methylprednisolone—multiple sclerosis	0.000148	0.000446	CcSEcCtD
Propafenone—Dysgeusia—Methotrexate—multiple sclerosis	0.000148	0.000446	CcSEcCtD
Propafenone—Body temperature increased—Triamcinolone—multiple sclerosis	0.000148	0.000445	CcSEcCtD
Propafenone—Oedema—Prednisone—multiple sclerosis	0.000148	0.000444	CcSEcCtD
Propafenone—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000147	0.000444	CcSEcCtD
Propafenone—Decreased appetite—Betamethasone—multiple sclerosis	0.000147	0.000444	CcSEcCtD
Propafenone—Decreased appetite—Dexamethasone—multiple sclerosis	0.000147	0.000444	CcSEcCtD
Propafenone—Nausea—Mitoxantrone—multiple sclerosis	0.000147	0.000443	CcSEcCtD
Propafenone—Infection—Prednisone—multiple sclerosis	0.000147	0.000442	CcSEcCtD
Propafenone—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000146	0.000441	CcSEcCtD
Propafenone—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000146	0.000441	CcSEcCtD
Propafenone—Fatigue—Betamethasone—multiple sclerosis	0.000146	0.00044	CcSEcCtD
Propafenone—Fatigue—Dexamethasone—multiple sclerosis	0.000146	0.00044	CcSEcCtD
Propafenone—Shock—Prednisone—multiple sclerosis	0.000145	0.000437	CcSEcCtD
Propafenone—Pain—Betamethasone—multiple sclerosis	0.000145	0.000436	CcSEcCtD
Propafenone—Pain—Dexamethasone—multiple sclerosis	0.000145	0.000436	CcSEcCtD
Propafenone—Nervous system disorder—Prednisone—multiple sclerosis	0.000145	0.000436	CcSEcCtD
Propafenone—Tachycardia—Prednisone—multiple sclerosis	0.000144	0.000434	CcSEcCtD
Propafenone—Skin disorder—Prednisone—multiple sclerosis	0.000143	0.000432	CcSEcCtD
Propafenone—Hyperhidrosis—Prednisone—multiple sclerosis	0.000143	0.00043	CcSEcCtD
Propafenone—Vision blurred—Methotrexate—multiple sclerosis	0.000142	0.000429	CcSEcCtD
Propafenone—Anorexia—Prednisone—multiple sclerosis	0.000141	0.000424	CcSEcCtD
Propafenone—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00014	0.000422	CcSEcCtD
Propafenone—Anaemia—Methotrexate—multiple sclerosis	0.00014	0.000421	CcSEcCtD
Propafenone—Feeling abnormal—Betamethasone—multiple sclerosis	0.00014	0.000421	CcSEcCtD
Propafenone—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00014	0.000421	CcSEcCtD
Propafenone—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000139	0.000417	CcSEcCtD
Propafenone—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000139	0.000417	CcSEcCtD
Propafenone—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000138	0.000414	CcSEcCtD
Propafenone—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000137	0.000413	CcSEcCtD
Propafenone—Malaise—Methotrexate—multiple sclerosis	0.000136	0.00041	CcSEcCtD
Propafenone—Vertigo—Methotrexate—multiple sclerosis	0.000136	0.000409	CcSEcCtD
Propafenone—Leukopenia—Methotrexate—multiple sclerosis	0.000135	0.000407	CcSEcCtD
Propafenone—Urticaria—Dexamethasone—multiple sclerosis	0.000135	0.000405	CcSEcCtD
Propafenone—Urticaria—Betamethasone—multiple sclerosis	0.000135	0.000405	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000134	0.000405	CcSEcCtD
Propafenone—Dizziness—Prednisolone—multiple sclerosis	0.000134	0.000404	CcSEcCtD
Propafenone—Asthenia—Triamcinolone—multiple sclerosis	0.000134	0.000404	CcSEcCtD
Propafenone—Body temperature increased—Betamethasone—multiple sclerosis	0.000134	0.000403	CcSEcCtD
Propafenone—Abdominal pain—Betamethasone—multiple sclerosis	0.000134	0.000403	CcSEcCtD
Propafenone—Abdominal pain—Dexamethasone—multiple sclerosis	0.000134	0.000403	CcSEcCtD
Propafenone—Body temperature increased—Dexamethasone—multiple sclerosis	0.000134	0.000403	CcSEcCtD
Propafenone—Asthenia—Methylprednisolone—multiple sclerosis	0.000134	0.000403	CcSEcCtD
Propafenone—Insomnia—Prednisone—multiple sclerosis	0.000133	0.000402	CcSEcCtD
Propafenone—Paraesthesia—Prednisone—multiple sclerosis	0.000133	0.000399	CcSEcCtD
Propafenone—Pruritus—Triamcinolone—multiple sclerosis	0.000132	0.000398	CcSEcCtD
Propafenone—Cough—Methotrexate—multiple sclerosis	0.000132	0.000397	CcSEcCtD
Propafenone—Pruritus—Methylprednisolone—multiple sclerosis	0.000132	0.000397	CcSEcCtD
Propafenone—Convulsion—Methotrexate—multiple sclerosis	0.000131	0.000394	CcSEcCtD
Propafenone—Dyspepsia—Prednisone—multiple sclerosis	0.00013	0.000391	CcSEcCtD
Propafenone—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	0.000129	0.00281	CbGpPWpGaD
Propafenone—Myalgia—Methotrexate—multiple sclerosis	0.000129	0.000387	CcSEcCtD
Propafenone—Chest pain—Methotrexate—multiple sclerosis	0.000129	0.000387	CcSEcCtD
Propafenone—Decreased appetite—Prednisone—multiple sclerosis	0.000128	0.000386	CcSEcCtD
Propafenone—Rash—Prednisolone—multiple sclerosis	0.000128	0.000386	CcSEcCtD
Propafenone—Dermatitis—Prednisolone—multiple sclerosis	0.000128	0.000385	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000128	0.000385	CcSEcCtD
Propafenone—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000127	0.000384	CcSEcCtD
Propafenone—Fatigue—Prednisone—multiple sclerosis	0.000127	0.000383	CcSEcCtD
Propafenone—Headache—Prednisolone—multiple sclerosis	0.000127	0.000383	CcSEcCtD
Propafenone—Discomfort—Methotrexate—multiple sclerosis	0.000127	0.000383	CcSEcCtD
Propafenone—SCN5A—Developmental Biology—PRNP—multiple sclerosis	0.000127	0.00276	CbGpPWpGaD
Propafenone—Constipation—Prednisone—multiple sclerosis	0.000126	0.00038	CcSEcCtD
Propafenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000125	0.00272	CbGpPWpGaD
Propafenone—Confusional state—Methotrexate—multiple sclerosis	0.000124	0.000374	CcSEcCtD
Propafenone—Dizziness—Triamcinolone—multiple sclerosis	0.000123	0.000372	CcSEcCtD
Propafenone—Dizziness—Methylprednisolone—multiple sclerosis	0.000123	0.000371	CcSEcCtD
Propafenone—Infection—Methotrexate—multiple sclerosis	0.000123	0.000369	CcSEcCtD
Propafenone—Feeling abnormal—Prednisone—multiple sclerosis	0.000122	0.000366	CcSEcCtD
Propafenone—Asthenia—Dexamethasone—multiple sclerosis	0.000122	0.000366	CcSEcCtD
Propafenone—Asthenia—Betamethasone—multiple sclerosis	0.000122	0.000366	CcSEcCtD
Propafenone—Nervous system disorder—Methotrexate—multiple sclerosis	0.000121	0.000364	CcSEcCtD
Propafenone—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000121	0.000364	CcSEcCtD
Propafenone—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000121	0.000363	CcSEcCtD
Propafenone—Nausea—Prednisolone—multiple sclerosis	0.000121	0.000363	CcSEcCtD
Propafenone—Pruritus—Betamethasone—multiple sclerosis	0.00012	0.000361	CcSEcCtD
Propafenone—Pruritus—Dexamethasone—multiple sclerosis	0.00012	0.000361	CcSEcCtD
Propafenone—Skin disorder—Methotrexate—multiple sclerosis	0.00012	0.000361	CcSEcCtD
Propafenone—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000119	0.000359	CcSEcCtD
Propafenone—Vomiting—Triamcinolone—multiple sclerosis	0.000119	0.000358	CcSEcCtD
Propafenone—Vomiting—Methylprednisolone—multiple sclerosis	0.000118	0.000357	CcSEcCtD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000118	0.00257	CbGpPWpGaD
Propafenone—Rash—Triamcinolone—multiple sclerosis	0.000118	0.000355	CcSEcCtD
Propafenone—Dermatitis—Triamcinolone—multiple sclerosis	0.000118	0.000354	CcSEcCtD
Propafenone—Anorexia—Methotrexate—multiple sclerosis	0.000118	0.000354	CcSEcCtD
Propafenone—Rash—Methylprednisolone—multiple sclerosis	0.000117	0.000354	CcSEcCtD
Propafenone—Dermatitis—Methylprednisolone—multiple sclerosis	0.000117	0.000353	CcSEcCtD
Propafenone—Urticaria—Prednisone—multiple sclerosis	0.000117	0.000353	CcSEcCtD
Propafenone—Headache—Triamcinolone—multiple sclerosis	0.000117	0.000352	CcSEcCtD
Propafenone—Headache—Methylprednisolone—multiple sclerosis	0.000117	0.000352	CcSEcCtD
Propafenone—Body temperature increased—Prednisone—multiple sclerosis	0.000117	0.000351	CcSEcCtD
Propafenone—Abdominal pain—Prednisone—multiple sclerosis	0.000117	0.000351	CcSEcCtD
Propafenone—ADRB1—GPCR ligand binding—GPR65—multiple sclerosis	0.000116	0.00254	CbGpPWpGaD
Propafenone—Diarrhoea—Betamethasone—multiple sclerosis	0.000116	0.000349	CcSEcCtD
Propafenone—Diarrhoea—Dexamethasone—multiple sclerosis	0.000116	0.000349	CcSEcCtD
Propafenone—Hypotension—Methotrexate—multiple sclerosis	0.000115	0.000347	CcSEcCtD
Propafenone—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	0.000114	0.00248	CbGpPWpGaD
Propafenone—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000112	0.000338	CcSEcCtD
Propafenone—Dizziness—Dexamethasone—multiple sclerosis	0.000112	0.000337	CcSEcCtD
Propafenone—Dizziness—Betamethasone—multiple sclerosis	0.000112	0.000337	CcSEcCtD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.000112	0.00244	CbGpPWpGaD
Propafenone—Insomnia—Methotrexate—multiple sclerosis	0.000112	0.000336	CcSEcCtD
Propafenone—Nausea—Triamcinolone—multiple sclerosis	0.000111	0.000334	CcSEcCtD
Propafenone—Paraesthesia—Methotrexate—multiple sclerosis	0.000111	0.000333	CcSEcCtD
Propafenone—Nausea—Methylprednisolone—multiple sclerosis	0.000111	0.000333	CcSEcCtD
Propafenone—Dyspnoea—Methotrexate—multiple sclerosis	0.00011	0.000331	CcSEcCtD
Propafenone—Somnolence—Methotrexate—multiple sclerosis	0.00011	0.00033	CcSEcCtD
Propafenone—Hypersensitivity—Prednisone—multiple sclerosis	0.000109	0.000327	CcSEcCtD
Propafenone—Dyspepsia—Methotrexate—multiple sclerosis	0.000109	0.000327	CcSEcCtD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000108	0.00236	CbGpPWpGaD
Propafenone—Vomiting—Betamethasone—multiple sclerosis	0.000108	0.000324	CcSEcCtD
Propafenone—Vomiting—Dexamethasone—multiple sclerosis	0.000108	0.000324	CcSEcCtD
Propafenone—Decreased appetite—Methotrexate—multiple sclerosis	0.000107	0.000323	CcSEcCtD
Propafenone—Rash—Betamethasone—multiple sclerosis	0.000107	0.000322	CcSEcCtD
Propafenone—Rash—Dexamethasone—multiple sclerosis	0.000107	0.000322	CcSEcCtD
Propafenone—Dermatitis—Dexamethasone—multiple sclerosis	0.000107	0.000321	CcSEcCtD
Propafenone—Dermatitis—Betamethasone—multiple sclerosis	0.000107	0.000321	CcSEcCtD
Propafenone—ADRB1—GPCR ligand binding—CXCL13—multiple sclerosis	0.000106	0.00232	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—CCR1—multiple sclerosis	0.000106	0.00232	CbGpPWpGaD
Propafenone—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000106	0.000321	CcSEcCtD
Propafenone—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	0.000106	0.00232	CbGpPWpGaD
Propafenone—Fatigue—Methotrexate—multiple sclerosis	0.000106	0.00032	CcSEcCtD
Propafenone—Headache—Betamethasone—multiple sclerosis	0.000106	0.00032	CcSEcCtD
Propafenone—Headache—Dexamethasone—multiple sclerosis	0.000106	0.00032	CcSEcCtD
Propafenone—Asthenia—Prednisone—multiple sclerosis	0.000106	0.000319	CcSEcCtD
Propafenone—Pain—Methotrexate—multiple sclerosis	0.000105	0.000318	CcSEcCtD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000105	0.00229	CbGpPWpGaD
Propafenone—Pruritus—Prednisone—multiple sclerosis	0.000104	0.000314	CcSEcCtD
Propafenone—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000104	0.00227	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000104	0.00227	CbGpPWpGaD
Propafenone—SCN5A—L1CAM interactions—MAPK1—multiple sclerosis	0.000104	0.00226	CbGpPWpGaD
Propafenone—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000103	0.00224	CbGpPWpGaD
Propafenone—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000103	0.00224	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—CD86—multiple sclerosis	0.000102	0.00223	CbGpPWpGaD
Propafenone—Feeling abnormal—Methotrexate—multiple sclerosis	0.000102	0.000306	CcSEcCtD
Propafenone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000102	0.00221	CbGpPWpGaD
Propafenone—Diarrhoea—Prednisone—multiple sclerosis	0.000101	0.000304	CcSEcCtD
Propafenone—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000101	0.000304	CcSEcCtD
Propafenone—Nausea—Betamethasone—multiple sclerosis	0.000101	0.000303	CcSEcCtD
Propafenone—Nausea—Dexamethasone—multiple sclerosis	0.000101	0.000303	CcSEcCtD
Propafenone—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	0.0001	0.00219	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—IL10—multiple sclerosis	0.0001	0.00219	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	9.96e-05	0.00217	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—PTPRC—multiple sclerosis	9.84e-05	0.00214	CbGpPWpGaD
Propafenone—Urticaria—Methotrexate—multiple sclerosis	9.8e-05	0.000295	CcSEcCtD
Propafenone—ABCB1—Allograft Rejection—IL4—multiple sclerosis	9.77e-05	0.00213	CbGpPWpGaD
Propafenone—Dizziness—Prednisone—multiple sclerosis	9.76e-05	0.000294	CcSEcCtD
Propafenone—Abdominal pain—Methotrexate—multiple sclerosis	9.75e-05	0.000294	CcSEcCtD
Propafenone—Body temperature increased—Methotrexate—multiple sclerosis	9.75e-05	0.000294	CcSEcCtD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	9.71e-05	0.00211	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	9.59e-05	0.00209	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	9.55e-05	0.00208	CbGpPWpGaD
Propafenone—ADRB1—G alpha (s) signalling events—POMC—multiple sclerosis	9.52e-05	0.00207	CbGpPWpGaD
Propafenone—Vomiting—Prednisone—multiple sclerosis	9.38e-05	0.000283	CcSEcCtD
Propafenone—Rash—Prednisone—multiple sclerosis	9.3e-05	0.00028	CcSEcCtD
Propafenone—Dermatitis—Prednisone—multiple sclerosis	9.3e-05	0.00028	CcSEcCtD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	9.26e-05	0.00202	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	9.25e-05	0.00201	CbGpPWpGaD
Propafenone—Headache—Prednisone—multiple sclerosis	9.24e-05	0.000278	CcSEcCtD
Propafenone—Hypersensitivity—Methotrexate—multiple sclerosis	9.09e-05	0.000274	CcSEcCtD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	9.01e-05	0.00196	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—FAS—multiple sclerosis	9e-05	0.00196	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	8.96e-05	0.00195	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	8.95e-05	0.00195	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	8.85e-05	0.00193	CbGpPWpGaD
Propafenone—Asthenia—Methotrexate—multiple sclerosis	8.85e-05	0.000266	CcSEcCtD
Propafenone—Nausea—Prednisone—multiple sclerosis	8.77e-05	0.000264	CcSEcCtD
Propafenone—Pruritus—Methotrexate—multiple sclerosis	8.73e-05	0.000263	CcSEcCtD
Propafenone—Diarrhoea—Methotrexate—multiple sclerosis	8.44e-05	0.000254	CcSEcCtD
Propafenone—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.34e-05	0.00182	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	8.32e-05	0.00181	CbGpPWpGaD
Propafenone—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.26e-05	0.0018	CbGpPWpGaD
Propafenone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.23e-05	0.00179	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—S1PR1—multiple sclerosis	8.16e-05	0.00178	CbGpPWpGaD
Propafenone—Dizziness—Methotrexate—multiple sclerosis	8.16e-05	0.000246	CcSEcCtD
Propafenone—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	8.09e-05	0.00176	CbGpPWpGaD
Propafenone—Vomiting—Methotrexate—multiple sclerosis	7.84e-05	0.000236	CcSEcCtD
Propafenone—Rash—Methotrexate—multiple sclerosis	7.78e-05	0.000234	CcSEcCtD
Propafenone—Dermatitis—Methotrexate—multiple sclerosis	7.77e-05	0.000234	CcSEcCtD
Propafenone—Headache—Methotrexate—multiple sclerosis	7.73e-05	0.000233	CcSEcCtD
Propafenone—ADRB1—GPCR ligand binding—CCL3—multiple sclerosis	7.59e-05	0.00165	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	7.49e-05	0.00163	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—CD80—multiple sclerosis	7.47e-05	0.00163	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.46e-05	0.00163	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.46e-05	0.00163	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—S1PR1—multiple sclerosis	7.41e-05	0.00161	CbGpPWpGaD
Propafenone—Nausea—Methotrexate—multiple sclerosis	7.33e-05	0.000221	CcSEcCtD
Propafenone—ADRB1—GPCR ligand binding—PTGER4—multiple sclerosis	7.3e-05	0.00159	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	7.27e-05	0.00158	CbGpPWpGaD
Propafenone—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.06e-05	0.00154	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—CXCR3—multiple sclerosis	7.05e-05	0.00154	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—RGS1—multiple sclerosis	6.94e-05	0.00151	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—CCR2—multiple sclerosis	6.86e-05	0.00149	CbGpPWpGaD
Propafenone—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	6.78e-05	0.00148	CbGpPWpGaD
Propafenone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.76e-05	0.00147	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	6.71e-05	0.00146	CbGpPWpGaD
Propafenone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.7e-05	0.00146	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	6.65e-05	0.00145	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—GPR65—multiple sclerosis	6.58e-05	0.00143	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	6.5e-05	0.00142	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	6.48e-05	0.00141	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	6.47e-05	0.00141	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	6.46e-05	0.00141	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	6.45e-05	0.0014	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—CNR1—multiple sclerosis	6.33e-05	0.00138	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—RGS1—multiple sclerosis	6.3e-05	0.00137	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—TYK2—multiple sclerosis	6.17e-05	0.00134	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	6.07e-05	0.00132	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	6.07e-05	0.00132	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—CCR1—multiple sclerosis	6.02e-05	0.00131	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—CXCL13—multiple sclerosis	6.02e-05	0.00131	CbGpPWpGaD
Propafenone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	6.01e-05	0.00131	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—GPR65—multiple sclerosis	5.98e-05	0.0013	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	5.9e-05	0.00129	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	5.81e-05	0.00126	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—LINGO1—multiple sclerosis	5.78e-05	0.00126	CbGpPWpGaD
Propafenone—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.72e-05	0.00125	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—CXCL10—multiple sclerosis	5.7e-05	0.00124	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CXCL13—multiple sclerosis	5.47e-05	0.00119	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CCR1—multiple sclerosis	5.47e-05	0.00119	CbGpPWpGaD
Propafenone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.45e-05	0.00119	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	5.42e-05	0.00118	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	5.27e-05	0.00115	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	5.25e-05	0.00114	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—IL2—multiple sclerosis	5.25e-05	0.00114	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	5.19e-05	0.00113	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.19e-05	0.00113	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.19e-05	0.00113	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	5.05e-05	0.0011	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.04e-05	0.0011	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	5.04e-05	0.0011	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TAGAP—multiple sclerosis	5.01e-05	0.00109	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.94e-05	0.00108	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—CCL5—multiple sclerosis	4.91e-05	0.00107	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—MMP9—multiple sclerosis	4.86e-05	0.00106	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—SRM—multiple sclerosis	4.72e-05	0.00103	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.7e-05	0.00102	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	4.7e-05	0.00102	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	4.54e-05	0.000988	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.44e-05	0.000968	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	4.44e-05	0.000967	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—CCR5—multiple sclerosis	4.42e-05	0.000963	CbGpPWpGaD
Propafenone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.42e-05	0.000962	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—TYK2—multiple sclerosis	4.4e-05	0.000959	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—S1PR1—multiple sclerosis	4.38e-05	0.000954	CbGpPWpGaD
Propafenone—CYP2C8—Biological oxidations—POMC—multiple sclerosis	4.37e-05	0.000952	CbGpPWpGaD
Propafenone—KCNH2—Neuronal System—MAPK1—multiple sclerosis	4.29e-05	0.000934	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—GPC5—multiple sclerosis	4.26e-05	0.000928	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—PTGER4—multiple sclerosis	4.13e-05	0.000899	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—SRM—multiple sclerosis	4.11e-05	0.000895	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	4.09e-05	0.000891	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—CXCR3—multiple sclerosis	3.99e-05	0.000868	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.98e-05	0.000868	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—MAPK1—multiple sclerosis	3.93e-05	0.000855	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CCL3—multiple sclerosis	3.89e-05	0.000848	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—CCR2—multiple sclerosis	3.88e-05	0.000845	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—SRM—multiple sclerosis	3.87e-05	0.000844	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—SRM—multiple sclerosis	3.84e-05	0.000836	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—TNF—multiple sclerosis	3.82e-05	0.000832	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PTGER4—multiple sclerosis	3.75e-05	0.000816	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—RGS1—multiple sclerosis	3.72e-05	0.000811	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CXCR3—multiple sclerosis	3.62e-05	0.000788	CbGpPWpGaD
Propafenone—CYP2D6—Biological oxidations—POMC—multiple sclerosis	3.59e-05	0.000782	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—CNR1—multiple sclerosis	3.58e-05	0.00078	CbGpPWpGaD
Propafenone—CYP2C9—Biological oxidations—POMC—multiple sclerosis	3.56e-05	0.000775	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—GPR65—multiple sclerosis	3.53e-05	0.000769	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.52e-05	0.000767	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CCR2—multiple sclerosis	3.52e-05	0.000767	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—MMP9—multiple sclerosis	3.47e-05	0.000755	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—POMC—multiple sclerosis	3.46e-05	0.000753	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—CCL2—multiple sclerosis	3.38e-05	0.000737	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	3.32e-05	0.000724	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	3.32e-05	0.000724	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SRM—multiple sclerosis	3.28e-05	0.000715	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CNR1—multiple sclerosis	3.25e-05	0.000708	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.25e-05	0.000708	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCR1—multiple sclerosis	3.23e-05	0.000703	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CXCL13—multiple sclerosis	3.23e-05	0.000703	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—CXCL10—multiple sclerosis	3.22e-05	0.000702	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—STAT3—multiple sclerosis	3.08e-05	0.000671	CbGpPWpGaD
Propafenone—CYP1A2—Biological oxidations—POMC—multiple sclerosis	3.04e-05	0.000662	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GPC5—multiple sclerosis	3.04e-05	0.000662	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—IL6—multiple sclerosis	3.02e-05	0.000657	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CXCL10—multiple sclerosis	2.93e-05	0.000637	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.9e-05	0.000631	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.9e-05	0.000631	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—TGFB1—multiple sclerosis	2.86e-05	0.000622	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—MAPK1—multiple sclerosis	2.8e-05	0.00061	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—CCL5—multiple sclerosis	2.77e-05	0.000604	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.73e-05	0.000594	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.73e-05	0.000594	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.71e-05	0.000589	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.71e-05	0.000589	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—TNF—multiple sclerosis	2.67e-05	0.000581	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GPC5—multiple sclerosis	2.65e-05	0.000577	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.64e-05	0.000576	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SRM—multiple sclerosis	2.53e-05	0.000552	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.52e-05	0.000549	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CCL5—multiple sclerosis	2.52e-05	0.000549	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—CCR5—multiple sclerosis	2.5e-05	0.000544	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.5e-05	0.000544	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.47e-05	0.000539	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—IL2RA—multiple sclerosis	2.46e-05	0.000536	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.35e-05	0.000511	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.31e-05	0.000503	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.31e-05	0.000503	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCL3—multiple sclerosis	2.3e-05	0.000501	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CCR5—multiple sclerosis	2.27e-05	0.000494	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.26e-05	0.000492	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL2RA—multiple sclerosis	2.24e-05	0.000487	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PTGER4—multiple sclerosis	2.21e-05	0.000482	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—RRM1—multiple sclerosis	2.19e-05	0.000478	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PGR—multiple sclerosis	2.18e-05	0.000475	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—IL6—multiple sclerosis	2.15e-05	0.000469	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CXCR3—multiple sclerosis	2.14e-05	0.000466	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CD28—multiple sclerosis	2.12e-05	0.000461	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.11e-05	0.00046	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCR2—multiple sclerosis	2.08e-05	0.000453	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—RRM1—multiple sclerosis	2.07e-05	0.00045	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—RRM1—multiple sclerosis	2.05e-05	0.000447	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.02e-05	0.000441	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.02e-05	0.00044	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.98e-05	0.000431	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.95e-05	0.000426	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—POMC—multiple sclerosis	1.95e-05	0.000425	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CNR1—multiple sclerosis	1.92e-05	0.000418	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.89e-05	0.000411	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.78e-05	0.000389	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.78e-05	0.000389	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—POMC—multiple sclerosis	1.77e-05	0.000386	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.75e-05	0.000382	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—CCL2—multiple sclerosis	1.74e-05	0.000378	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CXCL10—multiple sclerosis	1.73e-05	0.000377	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.68e-05	0.000366	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.63e-05	0.000355	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.59e-05	0.000346	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—TYK2—multiple sclerosis	1.58e-05	0.000343	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.53e-05	0.000333	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CD86—multiple sclerosis	1.51e-05	0.000329	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCL5—multiple sclerosis	1.49e-05	0.000324	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.45e-05	0.000315	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—IL2—multiple sclerosis	1.44e-05	0.000314	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SPP1—multiple sclerosis	1.38e-05	0.0003	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.37e-05	0.000298	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.36e-05	0.000296	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.35e-05	0.000294	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCR5—multiple sclerosis	1.34e-05	0.000292	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL2RA—multiple sclerosis	1.32e-05	0.000288	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL2—multiple sclerosis	1.31e-05	0.000286	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.27e-05	0.000276	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—BCHE—multiple sclerosis	1.26e-05	0.000275	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.25e-05	0.000271	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—APOE—multiple sclerosis	1.22e-05	0.000266	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.19e-05	0.000259	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.18e-05	0.000256	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.17e-05	0.000254	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CD80—multiple sclerosis	1.1e-05	0.00024	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.06e-05	0.000232	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—POMC—multiple sclerosis	1.05e-05	0.000228	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCL2—multiple sclerosis	1.03e-05	0.000223	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.01e-05	0.000219	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—MAPK1—multiple sclerosis	1e-05	0.000218	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TYK2—multiple sclerosis	9.31e-06	0.000203	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—APOE—multiple sclerosis	8.7e-06	0.00019	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.77e-06	0.000169	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL2—multiple sclerosis	7.75e-06	0.000169	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL6—multiple sclerosis	7.71e-06	0.000168	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—APOE—multiple sclerosis	7.58e-06	0.000165	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—POMC—multiple sclerosis	7.48e-06	0.000163	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MMP9—multiple sclerosis	7.33e-06	0.00016	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—APOE—multiple sclerosis	7.15e-06	0.000156	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—APOE—multiple sclerosis	7.08e-06	0.000154	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ALB—multiple sclerosis	6.82e-06	0.000148	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—STAT3—multiple sclerosis	6.52e-06	0.000142	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—POMC—multiple sclerosis	6.51e-06	0.000142	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—POMC—multiple sclerosis	6.14e-06	0.000134	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—POMC—multiple sclerosis	6.09e-06	0.000133	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MYC—multiple sclerosis	6.06e-06	0.000132	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—APOE—multiple sclerosis	6.05e-06	0.000132	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TGFB1—multiple sclerosis	6.04e-06	0.000132	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ALB—multiple sclerosis	5.94e-06	0.000129	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAPK1—multiple sclerosis	5.93e-06	0.000129	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ALB—multiple sclerosis	5.6e-06	0.000122	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ALB—multiple sclerosis	5.55e-06	0.000121	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—POMC—multiple sclerosis	5.2e-06	0.000113	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALB—multiple sclerosis	4.74e-06	0.000103	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APOE—multiple sclerosis	4.67e-06	0.000102	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL6—multiple sclerosis	4.55e-06	9.92e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—POMC—multiple sclerosis	4.01e-06	8.74e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALB—multiple sclerosis	3.66e-06	7.97e-05	CbGpPWpGaD
